CA3020090C - Inhibiteurs selectifs de pfkfb4 pour le traitement du cancer - Google Patents

Inhibiteurs selectifs de pfkfb4 pour le traitement du cancer

Info

Publication number
CA3020090C
CA3020090C CA3020090A CA3020090A CA3020090C CA 3020090 C CA3020090 C CA 3020090C CA 3020090 A CA3020090 A CA 3020090A CA 3020090 A CA3020090 A CA 3020090A CA 3020090 C CA3020090 C CA 3020090C
Authority
CA
Canada
Prior art keywords
present
cell
compound
absent
pfkfb4
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3020090A
Other languages
English (en)
Other versions
CA3020090A1 (fr
Inventor
Sucheta Telang
Jason Chesney
John O. Trent
Original Assignee
University of Louisville Research Foundation ULRF
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Louisville Research Foundation ULRF filed Critical University of Louisville Research Foundation ULRF
Priority claimed from PCT/US2016/028868 external-priority patent/WO2016172499A1/fr
Publication of CA3020090A1 publication Critical patent/CA3020090A1/fr
Application granted granted Critical
Publication of CA3020090C publication Critical patent/CA3020090C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

L'invention concerne des méthodes et des compositions pharmaceutiques pour inhiber la 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 (PFKFB4) et le traitement du cancer.
CA3020090A 2015-04-24 2016-04-22 Inhibiteurs selectifs de pfkfb4 pour le traitement du cancer Active CA3020090C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562152239P 2015-04-24 2015-04-24
US62/152,239 2015-04-24
PCT/US2016/028868 WO2016172499A1 (fr) 2015-04-24 2016-04-22 Inhibiteurs sélectifs de pfkfb4 pour le traitement du cancer

Publications (2)

Publication Number Publication Date
CA3020090A1 CA3020090A1 (fr) 2016-10-27
CA3020090C true CA3020090C (fr) 2025-12-09

Family

ID=

Similar Documents

Publication Publication Date Title
US12377087B2 (en) Compounds for the treatment of cancer
US11642347B2 (en) EZH2 inhibitors for treating lymphoma
CN113811333B (zh) 靶向抗癌核激素受体的化合物
AU2013362757B2 (en) Radiosensitizer compounds for use in combination with radiation
CN108349958A (zh) 用ezh2抑制剂治疗卵巢恶性横纹肌样瘤(mrto)/卵巢高钙血症型小细胞癌(sccoht)的方法
HUE025692T2 (en) Imidazo [4,5-c] quinoline derivatives as DNA-PK-pk inhibitors
US9884815B2 (en) PGAM1 inhibitors and methods related thereto
WO2024211314A2 (fr) Inhibiteurs de chd1l et leurs utilisations
US10266490B2 (en) Radioprotector compounds
US12258360B2 (en) Compositions and methods for treatment of anticancer-drug resistant cancers
CA3020090C (fr) Inhibiteurs selectifs de pfkfb4 pour le traitement du cancer
US10774046B2 (en) Inhibitors for the treatment of cancer and related methods
TW202108570A (zh) 抗癌核荷爾蒙受體標靶化合物
WO2025132831A1 (fr) Dérivés de n-hétéroaryle et leurs utilisations pour le traitement du cancer
WO2021046220A1 (fr) Composés et méthodes de traitement du cancer